Robert Wasinger, senior vice president on McGuireWoods Consulting’s federal public affairs team, was quoted in a Sept. 17 cover story by CQ Magazine.
Was Policy Fellow for House Oversight and Government Reform Committee
Greg Walden, partner at McGuireWoods and senior advisor with McGuireWoods Consulting, recently discussed legal concerns, ethical considerations and policy around autonomous vehicles with the Corporate Counsel Business Journal.
In a Sept. 10 opinion piece for The Hill, McGuireWoods Consulting executive vice president and director, Frank Donatelli, compares the upcoming midterm elections and modern politics to a heavyweight fight.
Former Educator Touts Strong Legislative Affairs Background
This Week: Ways and Means marks up HSA and other insurance-related legislation, CMS releases several payment rules … 340B discussed again … VA secretary nominee moves to the full Senate.
Your weekly North Carolina political news report.
The legislature adjourned following a grueling short session on Friday, June 29, 2018. The joint adjournment resolution includes an option to bring legislators back into session Tuesday, November 27, 2018 after the election. All 170 Senate and House seats across the state are contested on November 6. The Democrats seek to shift the power of the legislature, hoping to break the Republican supermajority in November. Once the legislature is back in session there are no restrictions on what legislation can be considered during the post-election session.
Number of the Week: 120
The number of days until the 2018 midterm elections. The latest polling data from RealClearPolitics has Democrats leading Republicans by 7.4 percentage points in a generic congressional ballot.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.